Emerald Health Sells Quebec Subsidiaries For $21.0 Million In Cash

Emerald Health Therapeutics (TSXV: EMH) is leaving Quebec. The company announced this morning that it is selling its Quebec-based subsidiaries Verdelite Sciences, Inc, as well as Verdelite Property Holdings, Inc in an all cash transaction to that of Quinto Resources (TSXV: QIT).

Under the terms of the transaction, Quinto will purchase the Quebec cannabis assets from Emerald Health for total consideration of $21.0 million, to be paid in cash. A $0.75 million holdback will be applied however for working capital adjustments and for “certain pre-existing litigation.”

Closing of the transaction is set to occur on or before August 31, 2020. Quinto, a public issuer whom will be required to conduct a “change of business,” and expects to finance the transaction via private placements and bridge financing.

Emerald Health has wholly-owned the license producer since May 1, 2018. Now, the company will retain only BC-based assets, including its Richmond facility, its Victoria facility, and its 41.3% stake in Pure Sunfarms, located in Delta, BC.

Emerald will still maintain the ability to sell into the Quebec market subject to certain restrictions.

Emerald Health Therapeutics last traded at $0.19 on the TSX Venture.


Information for this briefing was found via Sedar and Emerald Health Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Emerald Health Sees Revenues Decline 32% To $2.9 Million In First Quarter 2020

Revenues continue to decline for Emerald Health Therapeutics (TSXV: EMH), with the firm posting first...

Friday, June 19, 2020, 08:00:00 AM

Emerald Health Reduces Workforce 33%, Replaces CFO

Emerald Health Therapeutics (TSXV: EMH) made it known to the public this morning that it...

Wednesday, October 30, 2019, 10:42:23 AM

Emerald Health Announces Exit From Cannabis Industry

And another one bites the dust. Emerald Health Therapeutics (CSE: EMH), one of the first...

Monday, November 29, 2021, 08:20:51 AM

Village Farms Acquires Remainder Of Pure Sunfarms For C$79.9 Million

Well, it looks like Raymond James was on to something. This afternoon, it was announced...

Tuesday, September 8, 2020, 03:42:23 PM

Numerous Canadian Licensed Producers See Additional Licenses Granted

A number of Canadian licensed producers announced Health Canada approvals for expanded facilities this morning,...

Monday, October 7, 2019, 09:54:10 AM